2017 American Transplant Congress

Monday, May 1, 2017

8:30am-8:45am

Improving Communication of SRTR Transplant Program Outcomes Evaluations Using a 5-Tier System.

J. Snyder, A. Wey, N. Salkowski, A. Israni, B. Kasiske.

Joint Plenary Session II  •  Arie Crown Theater

8:45am-9:00am

Is the Current Heart Allocation System Just and Fair for Blood Type O Recipients? – A Propensity-Matched Analysis of 34353 Patients in the UNOS Registry.

M. Ando, K. Takeda, P. Kurlansky, M. Wright, C. Lee, J. Han, A. Garan, V. Topkara, M. Yuzefpolskaya, P. Colombo, M. Farr, Y. Naka, H. Takayama.

Joint Plenary Session II  •  Arie Crown Theater

9:00am-9:15am

MHC Class II-Peptide Complexes Displayed on Activated T Cells Guide Treg Suppression.

M. Fryer, S. Junius, S. Germana, L. Turka, C. LeGuern.

Joint Plenary Session II  •  Arie Crown Theater

9:15am-9:30am

HCC and Liver Transplantation Following the Recent Allocation Policy Change.

T. Ishaque, A. Massie, M. Bowring, J. Ruck, A. Cameron, B. Philosophe, D. Segev.

Joint Plenary Session II  •  Arie Crown Theater

2:30pm-2:42pm

Apolipoprotein L1 & Chronic Kidney Disease Risk in Young Potential Living Kidney Donors.

J. Locke,¹ D. Sawinski,² R. Reed,¹ B. Shelton,¹ P. MacLennan,¹ V. Kumar,¹ S. Mehta,¹ R. Mannon,¹ R. Gaston,¹ B. Julian,¹ J. Carr,³ J. Terry,³ M. Kilgore,¹ A. Massie,⁴ D. Segev,⁴ C. Lewis.¹

Concurrent Session: Living Kidney Donation: Post Donation Issues  •  E450b

2:30pm-2:42pm

A Proof of Concept for Liver Graft Modification Using Warm Ex Vivo Perfusion – “It Is Not Just About Rescuing Marginal Grafts”.

N. Goldaracena, J. Echeverri, N. Selzner, D. Grant, J. Feld, M. Selzner.

Concurrent Session: Emerging Interventions in Ischemia Reperfusion Injury  •  E351

2:30pm-2:42pm

BK Polyomavirus-Specific 9mer T-Cell Responses Predict Control of Viremia in Kidney Transplant Recipients: First Report from the Swiss Transplant Cohort Study.

H. Hirsch,¹ C. Leboeuf,¹ S. Wilk,¹ R. Achermann,² I. Binet,³ D. Golshayan,² K. Hadaya,² C. Hirzel,² M. Hoffmann,² U. Huynh-Do,² M. Koller,² O. Manuel,² N. Mueller,² T. Mueller,² S. Schaub,² C. Van Delden,² F. Weissbach.¹

Concurrent Session: Kidney BK Virus  •  E451a

2:30pm-2:42pm

BK Virus Infection and Risk of Urinary Tract Cancers Among Kidney Transplant Patients in the Transplant Cancer Match Study.

G. Gupta,¹ S. Kuppachi,² R. Kalil,² C. Buck,³ C. Lynch,² E. Engels.³

Concurrent Session: Infectious Complications of Transplant  •  E265

2:30pm-2:42pm

Circulating Donor-Specific Anti-HLA Antibodies Accelerate the Progression of Interstitial Fibrosis in Kidney Allografts.

C. Gosset, D. Viglietti, M. Rabant, E. Pillebout, A. Bouquegneau, J. Taupin, D. Glotz, C. Legendre, J. Duong Van-Huyen, A. Loupy, C. Lefaucheur.

Concurrent Session: Long Term Kidney Graft Survival I  •  E450a

2:30pm-2:42pm

CTLA4-Ig Inhibits Effector CD8⁺ T Cell Function In Vivo and Rescues Ongoing Acute Allograft Rejection.

J. Young,¹ S. Khiew,¹ J. Yang,¹ M.-L. Alegre,² A. Chong.¹

Concurrent Session: Mechanisms of Allograft Rejection  •  E352